TRVITrevi Therapeutics, Inc.
17.96USD-4.52%Mkt Cap: 2.56B $P/E: —3d ago
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IP…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.56B $
Enterprise Value2.28B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-42.76M $
Revenue/Share—
Last Price17.96 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees34
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-31.63
PEG—
EV/EBITDA-38.40
EV/Revenue—
P/S—
P/B8.09
EPS (TTM)-0.34
EPS (Forward)-0.58
52W Range
6.93083% of range20.15
52W High20.15 USD
52W Low6.930 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-23.33%
ROA-22.10%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-42.09M $
CapEx (TTM)12.00K $
FCF Margin—
FCF Yield-1.30%
Net Debt-318.27M $
Net Debt/EBITDA5.36
Balance Sheet
Debt/Equity0.00
Current Ratio37.28
Quick Ratio36.68
Book Value/Sh2.257 USD
Cash/Share2.238 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.18 USD
Upside (mean)+56.9%
Target Range23.00 USD – 40.00 USD
$23.00+56.9% to mean$40.00
# Analysts11
Ownership
Shares Out.142.48M
Float118.32M
Insiders0.63%
Institutions107.66%
Short Interest
Short Ratio5.0d
Short % Float10.24%
Short % Out.9.23%
Shares Short13.15M
Short (prev mo.)13.87M
Technical
SMA 5017.65 (+1.8%)
SMA 20013.69 (+31.2%)
Beta1.07
S&P 52W Chg18.16%
Avg Vol (30d)1.87M
Avg Vol (10d)1.51M
Technical Indicators
RSI (14)49.8
MACD0.2346
MACD Signal0.2894
MACD Hist.-0.0549
BB Upper19.03 USD
BB Middle18.18 USD
BB Lower17.32 USD
BB Width9.42%
ATR (14)0.9355 USD
Vol Ratio (20d)0.74x